Key result
Staged transfusion with continuous diuresis resolves refractory pulmonary edema, raising hemoglobin by ~1.8 g/dL in HFpEF.
Why the study?
Anemia in ischemic HFpEF and severe CAD aggravates myocardial hypoxia while posing a risk of transfusion-associated volume overload, leaving the optimal hemoglobin threshold for blood transfusion challenging and controversial.
Does an individualized, physiology-guided staged blood transfusion strategy with proactive loop diuresis improve clinical recovery and prevent volume overload in elderly patients with ischemic HFpEF and residual diffuse coronary artery disease?
Does an individualized, physiology-guided staged blood transfusion strategy with proactive loop diuresis improve clinical recovery and prevent volume overload in elderly patients with ischemic HFpEF and residual diffuse coronary artery disease?
In elderly patients with ischemic HFpEF and severe residual diffuse CAD, an individualized, physiology-guided blood transfusion approach paired with proactive loop diuresis may help balance myocardial oxygen delivery against the risk of volume overload rather than relying on rigid hemoglobin thresholds.
Answers are grounded in this paper and cite their sources.
Urges cautious transfusion thresholds in anemic ischemic HFpEF; leaves open optimal targets pending definitive trials.
Anemia frequently complicates ischemic heart failure with preserved ejection fraction (HFpEF) and severe coronary artery disease (CAD), aggravating myocardial hypoxia while posing an acute danger of transfusion-associated volume overload.In clinical critical care, determining the optimal hemoglobin threshold remains highly challenging and controversial.This opinion review explores the hemodynamic dilemmas, clinical trial evidence, and pathophysiological rationale of blood transfusion strategies in elderly patients with ischemic HFpEF and severe residual diffuse CAD following target-lesion percutaneous coronary intervention.Major randomized trials [including REALITY (randomized trial of red cell transfusion strategies in acute myocardial infarction) and MINT (myocardial ischemia and transfusion trial)] have demonstrated that liberal transfusion (targeting hemoglobin ≥ 10 g/dL) did not significantly reduce 30-day mortality or recurrent ischemic events compared with restrictive strategies (MINT: Relative risk = 1.15, 95% confidence interval: 0.99-1.34,P = 0.07; REALITY established noninferiority for the restrictive strategy regarding 30-day major adverse cardiovascular events without demonstrating clinical superiority of a liberal strategy), while heart failure rehospitalization rates remained largely comparable across arms.We report an 81-yearold female with permanent right ventricular pacing (75%), HFpEF (mitral E/e': 15, left atrial volume index: 36 mL/m 2 , tricuspid regurgitation velocity: 3.1 m/second), and diffuse small-vessel CAD who experienced recurrent flash pulmonary edema despite successful balloon angioplasty of an occluded mid-left anterior descending and an ostensibly adequate hemoglobin of 10.4 g/dL.Following comprehensive anemia screening ruling out absolute iron deficiency (ferritin: 152 ng/mL, transferrin saturation: 36%), staged blood transfusion (2 units over 48 hours) under continuous diuretic infusion successfully restored oxygen flux without volume overload.In our opinion, rather than adhering to rigid protocolized triggers, an individualized, physiology-guided approach incorporating bedside cardiac indices, non-linear hematologic biomarkers (hemoglobin, 4 / 27 red blood cell distribution width), and proactive loop diuresis should be considered.The complex clinical recovery involves concerted synergies among revascularization, guideline-directed neurohormonal therapies, and transfusion, serving as a hypothesisgenerating basis for future randomized trial.
No takes yet. Share an insight, caveat, or question.
HUNG et al. (2026) conducted a review in Ischemic heart failure with preserved ejection fraction and residual diffuse coronary artery disease with anemia (n=1). Staged packed red blood cell transfusion with continuous loop diuretic infusion was evaluated on Resolution of acute flash pulmonary edema and hemoglobin stabilization. Staged blood transfusion (2 units over 48 hours) with continuous diuresis increased hemoglobin from 10.4 to 12.2 g/dL and resolved recurrent pulmonary edema in an 81-year-old with ischemic HFpEF.
Synapse has enriched 10 related papers. Consider them for comparative context: